List of Fentora drug patents

Fentora is owned by Cephalon.

Fentora contains Fentanyl Citrate.

Fentora has a total of 4 drug patents out of which 0 drug patents have expired.

Fentora was authorised for market use on 25 September, 2006.

Fentora is available in tablet;buccal, sublingual dosage forms.

The generics of Fentora are possible to be released after 15 June, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8119158 CEPHALON Effervescent oral fentanyl dosage form and methods of administering fentanyl
Dec, 2024

(1 year, 10 months from now)

US8092832 CEPHALON Generally linear effervescent oral fentanyl dosage form and methods of administering
Dec, 2024

(1 year, 10 months from now)

US7862833 CEPHALON Effervescent oral opiate dosage forms and methods of administering opiates
Jun, 2028

(5 years from now)

US7862832 CEPHALON Generally linear effervescent oral fentanyl dosage form and methods of administering
Jun, 2028

(5 years from now)

Drugs and Companies using FENTANYL CITRATE ingredient

Market Authorisation Date: 25 September, 2006

Treatment: NA

Dosage: TABLET;BUCCAL, SUBLINGUAL

How can I launch a generic of FENTORA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in